| | |
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON [ ], 2026 |
| |
| | |
The proxy statement and the Annual Report are available at
https://www.proxyvote.com. |
| |
| | |
You may also obtain these materials at www.proxyvote.com and the U.S. Securities and Exchange
Commission website at www.sec.gov. |
| |
| |
Date and Time
|
| | December [ ], 2026 at [ ] [A./ P.M.], Eastern Time. | |
| |
Place
|
| | The 2026 Annual Meeting will be held solely by remote communication, in a virtual meeting format. You will be able to attend and participate in the Annual Meeting online, vote your shares electronically and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/GRDX2026, at the meeting date and time described in the accompanying proxy statement. You will not be able to attend the 2026 Annual Meeting in person. You will need the 16-digit control number on your proxy card to participate in the Annual Meeting. Beneficial owners of shares held in street name will need to follow the instructions provided by the broker, bank or other nominee that holds their shares. Online check-in will begin at [ ]. (Eastern), on [ ], 2026. Once admitted, you may participate in the meeting and vote during the Annual Meeting by following the instructions that will be available on the meeting website. | |
| |
Items of Business
|
| |
1.
Election of four director nominees named in this proxy statement, each for a term of one year expiring at our 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified (the “Director Election Proposal”);
2.
Adoption and approval of an amendment to our Amended and Restated Certificate of Incorporation, as amended (the “Charter”), to effect a reverse stock split of our issued and outstanding shares of Common Stock, at a specific ratio, ranging from 1:2 to 1:20, at any time prior to the one-year anniversary date of the Annual Meeting, with the exact ratio to be determined by the Board without further approval or authorization of our stockholders (the “Reverse Split Proposal”);
3.
To approve an amendment to the Company’s 2020 Omnibus Equity Incentive Plan (the “Plan”) to: (i) increase the number of shares of Common Stock authorized for issuance under the Plan from 3,801,549 to 10,000,000, including an increase in the number of shares available for grants of incentive stock options (“ISOs”) from 357 to 10,000,000; and (ii) increase the maximum number of shares that may be granted to any non-employee director in a calendar year from 250,000 to 6,500,000 (the “Equity Plan Amendment Proposal”).
4.
To approve the issuance of up to 1,520,000 shares of Common Stock upon the exercise of warrants issued or issuable pursuant to that certain Securities Purchase Agreement dated October 17, 2025, as amended to date, by and among the Company and the investors party thereto, as required by and in accordance with Nasdaq Listing Rule 5635(d) (the “Nasdaq Proposal”);
5.
Approval, on an advisory basis, of the executive compensation of the Company’s named executive officers as described in this proxy statement (the “Say on Pay Proposal”);
6.
Ratification of Macias Gini & O’Connell LLP, as our independent registered public accounting firm for the fiscal year ending December 31, 2026 (the “Auditor Ratification Proposal”); and
7.
Approval of the adjournment of the annual meeting to the extent there are insufficient proxies at the annual meeting to approve any one or more of the foregoing proposals (the “Adjournment Proposal”).
|
|
| |
Adjournments and Postponements
|
| | Any action on the items of business described above may be considered at the 2026 Annual Meeting at the time and on the date specified above or at any time and date to which the Annual Meeting may be properly adjourned or postponed. | |
| |
Record Date
|
| | October 20, 2026 (the “Record Date”). Only stockholders of record holding shares of our Common Stock, par value $0.0001 per share (the “Common Stock”) as of the close of business on the Record Date are entitled to notice of and to vote at the Annual Meeting. | |
| |
Meeting Admission
|
| | You are invited to attend the Annual Meeting if you are a stockholder of record or a beneficial owner of shares of our Common Stock as of the Record Date. | |
| | Availability of Proxy Materials | | | Copies of the proxy statement and our Annual Report on Form 10-K for the year ended December 31, 2025 are available at https://gridaipower.com. also obtain these materials at www.proxyvote.com and the U.S. Securities and Exchange Commission (“SEC”) website at www.sec.gov. | |
| | Voting | | | If your shares are held in the name of a bank, broker or other fiduciary, please follow the instructions on the proxy card. Whether or not you expect to attend the Annual Meeting, we urge you to submit your proxy to vote your shares as promptly as possible by following the instructions on your proxy card so that your shares may be represented and voted at the Annual Meeting. Your vote is very important. | |
| |
Boca Raton, Florida
[ ], 2026 |
| |
/s/ Jason D. Sawyer
Jason D. Sawyer
Chief Executive Officer and Director |
|
| | | |
Page
|
| |||
| | | | | 1 | | | |
| | | | | 9 | | | |
| | | | | 15 | | | |
| | | | | 33 | | | |
| | | | | 34 | | | |
| | | | | 42 | | | |
| | | | | 49 | | | |
| | | | | 51 | | | |
| | | | | 52 | | | |
| | | | | 55 | | | |
| | | | | 56 | | | |
| | | | | 56 | | | |
| | | | | 57 | | | |
| | | | | 57 | | | |
| | | | | 57 | | | |
| | | | | A-1 | | | |
| | | | | B-1 | | | |
|
Proposal No.
|
| |
Required Vote for Approval
|
|
|
1.
|
| | Election of Directors (the “Director Election Proposal”). The four director nominees who receive the highest number of affirmative votes cast by shares of our Common Stock present or represented by proxy and entitled to vote at the Annual Meeting will be elected. | |
| 2. | | | Adoption and approval of an amendment to our Amended and Restated Certificate of Incorporation, as amended (the “Charter”), to effect a reverse stock split of our issued and outstanding shares of Common Stock, at a specific ratio, ranging from 1:2 to 1:20, at any time prior to the one-year anniversary date of the Annual Meeting, with the exact ratio to be determined by the Board without further approval or authorization of our stockholders (the “Reverse Split Proposal”). This proposal requires the affirmative (“FOR”) vote of a majority of votes cast by shares of our Common Stock present or represented by proxy and entitled to vote at the Annual Meeting. Shares that are not represented at the Annual Meeting, abstentions and broker non-votes, if any, with respect to this proposal are not counted as votes cast and will not affect the outcome of the voting on this proposal. | |
| 3. | | | To approve an amendment to the Company’s 2020 Omnibus Equity Incentive Plan (the “Plan”) to: (i) increase the number of shares of Common Stock authorized for issuance under the Plan from 3,801,549 to 10,000,000, including an increase in the number of shares available for grants of incentive stock options (“ISOs”) from 357 to 10,000,000; and (ii) increase the maximum number of shares that may be granted to any non-employee director in a calendar year from 250,000 to 6,500,000 (the “Equity Plan Amendment Proposal”). This proposal requires the affirmative (“FOR”) vote of a majority of votes cast by shares of our Common Stock present or represented by proxy and entitled to vote at the Annual Meeting. Shares that are not represented at the Annual Meeting, abstentions and broker non-votes, if any, with respect to this proposal are not counted as votes cast and will not affect the outcome of such proposal. | |
|
Proposal No.
|
| |
Required Vote for Approval
|
|
| 4. | | | To approve the issuance of up to 1,520,000 shares of Common Stock upon the exercise of warrants issued or issuable pursuant to that certain Securities Purchase Agreement dated October 17, 2025, as amended to date, by and among the Company and the investors party thereto, as required by and in accordance with Nasdaq Listing Rule 5635(d) (the “Nasdaq Proposal”). This proposal requires the affirmative (“FOR”) vote of a majority of votes cast by shares of our Common Stock present or represented by proxy and entitled to vote at the Annual Meeting. Shares that are not represented at the Annual Meeting, abstentions and broker non-votes, if any, with respect to this proposal are not counted as votes cast and will not affect the outcome of the voting on this proposal. | |
|
5.
|
| | Approval, on an advisory basis, of the executive compensation of the Company’s named executive officers as described in this proxy statement (the “Say on Pay Proposal”). This proposal requires the affirmative (“FOR”) vote of a majority of votes cast by shares of our Common Stock present or represented by proxy and entitled to vote at the Annual Meeting. Shares that are not represented at the Annual Meeting, abstentions and broker non-votes, if any, with respect to this proposal are not counted as votes cast and will not affect the outcome of the voting on this proposal. | |
|
6.
|
| | Ratification of Macias Gini & O’Connell LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 (the “Auditor Ratification Proposal”). To approve the ratification of Macias Gini & O’Connell LLP as our independent registered public accounting firm for the current fiscal year. This proposal requires the affirmative (“FOR”) vote of a majority of votes cast by shares of our Common Stock present or represented by proxy and entitled to vote at the Annual Meeting. Shares that are not represented at the Annual Meeting and abstentions, if any, with respect to this proposal are not counted as votes cast and will not affect the outcome of the voting on this proposal. | |
|
7.
|
| | Approval of the Adjournment of the Annual Meeting to the Extent There Are Insufficient Proxies at the Annual Meeting to Approve Any One or More of the Foregoing Proposals. To approve the adjournment of the Annual Meeting in the event that the number of shares of Common Stock present or represented by proxy at the Annual Meeting and voting “FOR” the adoption of any one or more of the foregoing proposals are insufficient to approve any proposal. This proposal requires the affirmative (“FOR”) vote of a majority of votes cast by shares of our Common Stock present or represented by proxy and entitled to vote at the Annual Meeting. Shares that are not represented at the Annual Meeting, abstentions and broker non-votes, if any, with respect to this proposal are not counted as votes cast and will not affect the outcome of the voting on this proposal. | |
|
Director, Title
|
| |
Age
|
| |||
|
Edward J. Borkowski – Chairman
|
| | | | 66 | | |
|
Jason D. Sawyer
|
| | | | 54 | | |
|
Jack Syage, Ph.D
|
| | | | 71 | | |
|
Geordan G. Pursglove
|
| | | | 37 | | |
|
Non-Executive Directors
|
| |
Fees Earned or
Paid in Cash(1) |
| |
Stock
Award(2) |
| |
Option
Award |
| |
All Other
Compensation |
| |
Total
|
| |||||||||||||||
|
Edward J. Borkowski
|
| | | $ | 70,841 | | | | | $ | 93,200 | | | | | $ | — | | | | | $ | — | | | | | $ | 164,041 | | |
|
Manpreet Uppal(3)
|
| | | $ | 40,787 | | | | | $ | 93,200 | | | | | $ | — | | | | | $ | — | | | | | $ | 133,987 | | |
|
Geordan G. Pursglove
|
| | | $ | 18,125 | | | | | $ | 93,200 | | | | | $ | — | | | | | $ | — | | | | | $ | 111,325 | | |
|
Eric Corbett(3)
|
| | | $ | 33,915 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 33,915 | | |
|
Jason Sawyer
|
| | | $ | 12,500 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 12,500 | | |
|
Jack Syage
|
| | | $ | 26,518 | | | | | $ | 93,200 | | | | | $ | — | | | | | $ | — | | | | | $ | 119,718 | | |
| | | |
Committees
|
| |||||||||||||||
|
Director
|
| |
Board
|
| |
Audit
|
| |
Compensation
|
| |||||||||
|
Edward J. Borkowski
|
| | | | C | | | | | | CC | | | | | | CC | | |
|
Jason D. Sawyer
|
| | | | X | | | | | | | | | | | | | | |
|
Jack Syage, Ph.D
|
| | | | X | | | | | | X | | | | | | X | | |
|
Geordan G. Pursglove
|
| | | | X | | | | | | X | | | | | | | | |
|
Meetings Held During 2025
|
| | | | 9 | | | | | | 4 | | | | | | 1 | | |
|
Actions Taken by UWC During 2025
|
| | | | 5 | | | | | | 0 | | | | | | 2 | | |
|
Executive Officer
|
| |
Age
|
| |
Title
|
| |||
|
Jason D. Sawyer
|
| | | | 54 | | | | Chief Executive Officer | |
|
Anna Skowron
|
| | | | 39 | | | |
Interim Chief Financial Officer
|
|
|
Named Executive Officers
|
| |
Year
|
| |
Salary
|
| |
Bonus
|
| |
Stock
Award |
| |
All Other
Compensation |
| |
Total
|
| ||||||||||||||||||
|
Jason Sawyer (CEO)
|
| | | | 2025 | | | | | $ | | | | | $ | — | | | | | $ | 93,200(1) | | | | | $ | 87,500(2) | | | | | $ | 180,700 | | | |
|
Richard Paolone (Former CEO)(6)
|
| | | | 2025 | | | | | | 87,500 | | | | | | — | | | | | | | | | | | | 15,228(3) | | | | | | 102,728 | | |
|
James Sapirstein (Former CEO)
|
| | | | 2024 | | | | | | 416,300 | | | | | | — | | | | | | 76,400(4) | | | | | | 17,608(5) | | | | | | 510,308 | | |
|
Anna Skowron
|
| | | | 2025 | | | | | | 103,387 | | | | | | — | | | | | | 151,450(1) | | | | | | — | | | | | | 254,837 | | |
|
Sarah Romano (Former CFO)
|
| | | | 2024 | | | | | | 390,550 | | | | | | 117,165(1) | | | | | | 185,676(4) | | | | | | 117,165 | | | | | | 810,556 | | |
|
Plan category
|
| |
Number of
securities to be issued upon exercise of outstanding options, warrants and rights |
| |
Weighted-average
exercise price of Outstanding option, warrants and rights |
| |
Number of
securities remaining available for future issuance under equity compensation plans reflected in column (a) |
| |||||||||
| | | |
(a)
|
| | | | | | | |||||||||
|
Equity compensation plans approved by security holders(1)
|
| | | | 19 | | | | | $ | 39,125 | | | | | | 941,100 | | |
|
Equity compensation plans not approved by security holders
|
| | | | — | | | | | | — | | | | | | — | | |
| Total | | | | | 19 | | | | | $ | 39,125 | | | | | | 941,100 | | |
| Year | | | PEO 1 SCT | | | PEO 1 CAP | | | PEO 2 SCT | | | PEO 2 CAP | | | Non-PEO avg. SCT | | | Non-PEO avg. CAP | | | TSR ($100) | | | Net loss ($) | | ||||||||||||||||||||||||
| 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ( | | | |||||||
| 2024 | | | | | | | | | | | | | | | — | | | | | | — | | | | | | | | | | | | | | | | | | | | | ( | | | |||||
| 2023 | | | | | | | | | | | | | | | — | | | | | | — | | | | | | | | | | | | | | | | | | | | | ( | | | |||||
| 2025 executive | | | SCT total ($) | | | Less grant-date awards ($) | | | Add vest-date value ($) | | | CAP ($) | | ||||||||||||
| Jason D. Sawyer | | | | | | | | | | ( | | | | | | | | | | | | | |||
| Richard Paolone | | | | | | | | | | — | | | | | | — | | | | | | | | ||
| Anna Skowron | | | | | | | | | | ( | | | | | | | | | | | | | |||
|
Name and Address of Beneficial Owner(1)
|
| |
Number of
Shares(2) |
| |
Percentage of
Ownership(3) |
| ||||||
| Current Executive Officers and Directors | | | | | | | | | | | | | |
|
Jason Sawyer, Chief Executive Officer(4)
|
| | | | 1,080,000 | | | | | | 10.6% | | |
|
Anna Skowron, Interim Chief Financial Officer
|
| | | | 140,000 | | | | | | 1.4% | | |
|
Edward J. Borkowski, Director
|
| | | | 277,327 | | | | | | 2.7% | | |
|
Geordan Pursglove, Director
|
| | | | 140,000 | | | | | | 1.4% | | |
|
Jack Syage, Director
|
| | | | 80,000 | | | | | | * | | |
|
All directors and executive officers as a group (5 persons)
|
| | | | 1,717,327 | | | | | | 16.6% | | |
| | | |
Current
|
| |
1:2
|
| |
1:20
|
| |||||||||
|
Common Stock Authorized
|
| | | | 100,000,000 | | | | | | 100,000,000 | | | | | | 100,000,000 | | |
|
Common Stock Issued and Outstanding
|
| | | | 8,540,172 | | | | | | 4,270,086 | | | | | |
approximately 427,009 |
| |
|
Number of Shares of Common Stock Reserved for
Issuance |
| | | | 45,198,231 | | | | | | 22,599,116 | | | | | | 2,259,912 | | |
|
Number of Shares of Common Stock Authorized but Unissued and Unreserved
|
| | | | 46,261,597 | | | | | | 73,130,798 | | | | | | 97,313,079 | | |
|
Price per share, based on the closing price of our Common Stock
on the Record Date |
| | | $ | 4.63 | | | | | $ | 9.26 | | | | | $ | 92.60 | | |
|
Plan category
|
| |
Number of
securities to be issued upon exercise of outstanding options, warrants and rights |
| |
Weighted-average
exercise price of outstanding option, warrants and rights |
| |
Number of
securities remaining available for future issuance under equity compensation plans reflected in column (a) |
| |||||||||
|
Equity compensation plans approved by security
holders(1) |
| | | | 19 | | | | | $ | 39,125 | | | | | | 941,100 | | |
|
Equity compensation plans not approved by security
holders |
| | | | — | | | | | | — | | | | | | — | | |
|
Total
|
| | | | 19 | | | | | $ | 39,125 | | | | | | 941,100 | | |
| | | |
For the years ended
|
| |||||||||
| | | |
December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Audit fees(1)
|
| | | $ | 360,150 | | | | | $ | 280,500 | | |
|
Audit-related fees(2)
|
| | | | 53,000 | | | | | | 227,700 | | |
|
Tax fees
|
| | | | — | | | | | | — | | |
|
All other fees(3)
|
| | | | — | | | | | | 20,249 | | |
|
Total
|
| | | $ | 413,150 | | | | | $ | 528,449 | | |
| |
Boca Raton, Florida
[ ], 2026 |
| |
/s/ Jason D. Sawyer
Jason D. Sawyer
Chief Executive Officer and Director |
|